The valuation for bio stocks are hard.
IVX & RAP, fetched $300m.
BIT, potential HIV cure drug. Gilead's one HIV inhibitor drug achieved annual revenue of US$3.5b.
You can see how the market is excite about BIT225, kill HIV viruses.
BIT Price at posting:
31.5¢ Sentiment: Buy Disclosure: Held
